» Articles » PMID: 17152269

Cadherin Expression in Ovarian Carcinoma and Malignant Mesothelioma Cell Effusions

Overview
Journal Acta Cytol
Publisher Karger
Specialty Cell Biology
Date 2006 Dec 13
PMID 17152269
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyze potential differences in cadherin expression between ovarian carcinoma/primary peritoneal carcinoma (OC/PPC) and malignant mesothelioma (MM) at this anatomic site.

Study Design: MM (N=24) and OC/PPC (N= 53) effusions were analyzed for E-cadherin, N-cadherin and P-cadherin protein expression using immunocytochemistry.

Results: Both MM and OC/PPC cells showed frequent expression of all 3 cadherins. OC/PPC specimens expressed E-cadherin and N-cadherin in 52 of 53 cases and P-cadherin in 51 of 53 cases. MM effusions expressed E-cadherin, N-cadherin and P-cadherin in 22 of 24, 21 of24 and 23 of24 cases, respectively. The differences in the percentage of cadherin-positive cells was weakly significant for P-cadherin (higher expression in MM, p = 0.04), but E-cadherin and N-cadherin expression was comparable (p > 0.05).

Conclusion: MM and OC/PPC coexpress different cadherin family members. P-cadherin, E-cadherin and N-cadherin are not useful for differentiation between OC/PPC and MM in effusions.

Citing Articles

NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.

Gabbasov R, Xiao F, Howe C, Bickel L, OBrien S, Benrubi D Oncogene. 2018; 37(35):4854-4870.

PMID: 29773902 PMC: 6119087. DOI: 10.1038/s41388-018-0296-y.


Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.

Klymenko Y, Kim O, Stack M Cancers (Basel). 2017; 9(8).

PMID: 28792442 PMC: 5575607. DOI: 10.3390/cancers9080104.


Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.

Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E Neoplasia. 2017; 19(7):549-563.

PMID: 28601643 PMC: 5497527. DOI: 10.1016/j.neo.2017.04.002.


SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

Sheets J, Iwanicki M, Liu J, Howitt B, Hirsch M, Gubbels J Oncogenesis. 2016; 5(10):e264.

PMID: 27775699 PMC: 5117850. DOI: 10.1038/oncsis.2016.64.


HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin.

Ko S, Naora H Mol Cancer. 2014; 13:170.

PMID: 25023983 PMC: 4105245. DOI: 10.1186/1476-4598-13-170.